These proposals aim to improve corporate governance and ultimately future shareholder returns at Argonaut
mission represents the responsiveness of commercial partners.
Best also has withdrawn the ICR of "bbb" of Argonaut
CONTACT: Lissa Goldenstein, Chief Executive Officer of Argonaut
Technologies, +1-650-716-1600, or investor@argotech.
PXRE and its directors and executive officers and Argonaut
A webcast replay of the conference call will be available approximately one hour after the call's completion on Argonaut
Group's investor relations Web page at www.
is a leading provider of consumables, instruments, and services designed to help the pharmaceutical industry accelerate drug development.
Payment of the dividend is not contingent upon the consummation of the proposed merger transaction between Argonaut
and PXRE Group Ltd.
Technologies intends to distribute a significant portion of the net proceeds received in the sale to stockholders promptly after the closing of the transaction, which is subject to stockholder approval and other customary closing conditions.
Best has also affirmed the FSR of A- (Excellent) and the ICR of "a-" for Argonaut
Great Central Insurance Company (AGC) (Peoria, IL).
Group's board of directors has set a record date of June 4, 2007 for determining shareholders of record entitled to vote at the special meeting.
We welcome the addition of Frank Husic to the Argonaut
Technologies board," said Lissa A.
Technologies , a leading provider of chemistry instruments and consumables to help the pharmaceutical industry accelerate drug development, announced the relocation of its corporate headquarters and an ancillary office, resulting in a significant cost savings going forward.
SAN ANTONIO & HAMILTON, Bermuda -- Argonaut
Technologies marks the company's advance into pharmaceutical bioanalysis with the publication of their 2004/2005 Catalog of Bioanalytical Sample Preparation Products.